Investors & Partners

LifeSplice is a privately funded biotechnology company developing products for the treatment of severe neurological and non-neurological diseases with critical unmet needs.

LifeSplice's proprietary drug discovery technology offers partners a valuable mechanism to rapidly identify and initiate preclinical product development across a broad range of therapeutic areas including cancer, infectious diseases, and rare genetic disorders.

Companies interested in early-stage partnership and discovery opportunities should contact LifeSplice directly at partners@lifesplicepharma.com.

LifeSplice has multiple investment strategies available and interested investors should contact LifeSplice directly at invest@lifesplicepharma.com.